Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel. It operates as a former subsidiary of Clal Industries and Investments Ltd.
Frequently asked questions
What sector does Clal Biotechnology Industries Ltd (CBI) operate in?
Clal Biotechnology Industries Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Clal Biotechnology Industries Ltd (CBI) current stock price?
As of the latest data, Clal Biotechnology Industries Ltd stock price is ₪0.24, with a previous close of ₪0.24. Clal Biotechnology Industries Ltd lost -₪0.00 in the last trading session, representing a -1.65% loss.
What is Clal Biotechnology Industries Ltd (CBI) current market capitalization?
Clal Biotechnology Industries Ltd market cap is approximately 37.49 million.
What is Clal Biotechnology Industries Ltd (CBI) Earnings Per Share (EPS)?
The trailing EPS is -₪0.09.
Does Clal Biotechnology Industries Ltd (CBI) pay dividends?
No. Clal Biotechnology Industries Ltd does not pay a dividend.
What is Clal Biotechnology Industries Ltd (CBI) beta (volatility) score?
Clal Biotechnology Industries Ltd has a beta of 0.355, indicating lower volatility than the overall market.
